Dirk Lange CEO

Dirk Lange

President and CEO
 

Dirk Lange

President and CEO

Dirk Lange began serving as President and CEO of KBI Biopharma in February of 2020. Prior to being appointed President and CEO, Dirk served as KBI’s Chief Operating Officer. His previous roles at KBI include Senior Vice President of Operations and Site Head in Boulder, CO as well as Vice President positions in Operations and Business Development.

Before returning to the US in 2016, Dirk was Head of External Supply Operations at Novartis Biologics in Basel, Switzerland and held leadership positions in Operations, Program Management, and Business Development at Sandoz Oncology Injectables in Austria, and Rentschler Biopharma in Germany. Dirk has extensive experience in technical operations, quality remediation, supply chain, and third-party operations. Dirk has also led several Drug Substance and Drug Product Sites through successful Health Authority inspections including FDA, EMA and ANVISA. Dirk received his Master Professional (CCI) of Technical Management in 2005 and his Bachelor Professional (CCI) of Pharmaceutical Technology in 2002. Dirk also taught Economics and Operations Management at Chamber of Commerce and Industry in Ulm, Germany.